Drug Trial Radar · NCT02112578
Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
Last checked: Nov 20, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
292
Actual
Start
Nov 1, 2016
Primary completion
Apr 1, 2017
Study completion Dec 1, 2017
Sponsor
- Lead sponsor
- Apsen Farmaceutica S.A.Industry
- Sponsor type
- Industry
- First posted
- Apr 14, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
* Evaluation of the non inferiority of Meclin (meclizine) versus Dramin (Dimenhydrinate) to treat the symptoms of acute vertigo from peripheral origin after up to 4 weeks of treatment; * Evaluation of impact on quality of life in vertigo; * Compare the intensity of daytime sleepiness in the two treatment groups; * Compare the efficacy of drugs in relieving each of the 10 symptoms that make up the VS; * Compare the duration of treatment in both treatment groups; * Compare Adehence; * Compare the level of satisfaction from each group from the investigators and the subjects; * Adverse events;
Conditions
- Vertigo, Peripheral
Interventions
MeclizineDrug
25 mg, 3 times per day up to 30 days
DimenhydrinateDrug
50 mg, 3 times per day up to 30 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vertigo Score (VS)Time frame: up to 30 days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Clinilive
Maringá, Paraná, Brazil
Alergoalpha
Barueri, São Paulo, Brazil
Pesquisare Saude S/S Ltda
Santo André, São Paulo, Brazil
ISPEM
São José dos Campos, São Paulo, Brazil
CCBR SP
São Paulo, São Paulo, Brazil
Irmandade da Santa Casa de Misericórdia de São Paulo
São Paulo, São Paulo, Brazil
Clinica de Alergia MarttiAntila
Sorocaba, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.